Log in to save to my catalogue

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d039bcb285fa4e649b115719a170433f

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential

About this item

Full title

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential

Publisher

London: BioMed Central Ltd

Journal title

BMC pharmacology & toxicology, 2022-07, Vol.23 (1), p.1-58, Article 58

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

The present study aims to investigate the newly synthesized organotin (IV) complex (2E, 2'E) dibutylstannanediyl bis (4-(4-nitrophenyl) amino)-4-oxobut-2-enoate (DTN) for its anti-ulcer potential. Characterization performed by carbon nuclear magnetic resonance spectroscopy proved that all values are in the expected ranges of the new compound. Gastr...

Alternative Titles

Full title

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d039bcb285fa4e649b115719a170433f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d039bcb285fa4e649b115719a170433f

Other Identifiers

ISSN

2050-6511

E-ISSN

2050-6511

DOI

10.1186/s40360-022-00596-0

How to access this item